Financhill
Buy
55

BCPC Quote, Financials, Valuation and Earnings

Last price:
$157.14
Seasonality move :
5.85%
Day range:
$155.83 - $158.03
52-week range:
$139.17 - $177.40
Dividend yield:
0.56%
P/E ratio:
34.28x
P/S ratio:
5.05x
P/B ratio:
3.91x
Volume:
150.2K
Avg. volume:
204.9K
1-year change:
-5.26%
Market cap:
$5.1B
Revenue:
$953.7M
EPS (TTM):
$4.57

Analysts' Opinion

  • Consensus Rating
    Balchem Corp. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $191.00, Balchem Corp. has an estimated upside of 21.66% from its current price of $156.63.
  • Price Target Downside
    According to analysts, the lowest downside price target is $162.00 representing 100% downside risk from its current price of $156.63.

Fair Value

  • According to the consensus of 2 analysts, Balchem Corp. has 21.66% upside to fair value with a price target of $191.00 per share.

BCPC vs. S&P 500

  • Over the past 5 trading days, Balchem Corp. has underperformed the S&P 500 by -3.01% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Balchem Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Balchem Corp. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Balchem Corp. reported revenues of $267.6M.

Earnings Growth

  • Balchem Corp. has grown year-over-year earnings for 10 quarters straight. In the most recent quarter Balchem Corp. reported earnings per share of $1.24.
Enterprise value:
5.2B
EV / Invested capital:
3.53x
Price / LTM sales:
5.05x
EV / EBIT:
25.27x
EV / Revenue:
5.12x
PEG ratio (5yr expected):
1.51x
EV / Free cash flow:
32.13x
Price / Operating cash flow:
31.65x
Enterprise value / EBITDA:
20.78x
Gross Profit (TTM):
$363.1M
Return On Assets:
9.14%
Net Income Margin (TTM):
14.72%
Return On Equity:
12.23%
Return On Invested Capital:
10.45%
Operating Margin:
20.52%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $926.3M $942.4M $1B $239.9M $267.6M
Gross Profit $295.7M $324.9M $363.1M $85.4M $95.5M
Operating Income $167.4M $196M $205.4M $48.2M $54.9M
EBITDA $222.2M $246.6M $249.8M $59.1M $66.5M
Diluted EPS $3.19 $3.72 $4.57 $1.03 $1.24
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $300.3M $368.1M $341.2M $326M $343.7M
Total Assets $1.2B $1.6B $1.6B $1.6B $1.7B
Current Liabilities $104.9M $142.1M $108M $109.4M $126.4M
Total Liabilities $290.3M $737.1M $578.2M $419.7M $363.2M
Total Equity $889.1M $895.9M $1B $1.2B $1.3B
Total Debt $118M $473M $396.1M $242.1M $168.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $158M $197.1M $201.6M $51.3M $65.6M
Cash From Investing -$37.4M -$34.6M -$64.4M -$9.2M -$14.9M
Cash From Financing -$104.6M -$168.7M -$146.8M -$34.4M -$50.8M
Free Cash Flow $117.2M $162.6M $161.6M $42.2M $50.7M
BCPC
Sector
Market Cap
$5.1B
$21.4M
Price % of 52-Week High
88.28%
72.73%
Dividend Yield
0.56%
0%
Shareholder Yield
1.98%
-2.62%
1-Year Price Total Return
-5.13%
12.66%
Beta (5-Year)
0.992
0.620
Dividend yield:
0.56%
Annualized payout:
$0.87
Payout ratio:
--
Growth streak:
15 years

Technicals

8-day SMA
Sell
Level $157.51
200-day SMA
Sell
Level $158.05
Bollinger Bands (100)
Buy
Level 149.17 - 160.31
Chaikin Money Flow
Buy
Level 29.7M
20-day SMA
Buy
Level $155.00
Relative Strength Index (RSI14)
Buy
Level 53.62
ADX Line
Buy
Level 19.01
Williams %R
Neutral
Level -30.1068
50-day SMA
Buy
Level $153.92
MACD (12, 26)
Buy
Level 1.03
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Neutral
Level 25.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (8.9489)
Buy
CA Score (Annual)
Level (1.1175)
Buy
Beneish M-Score (Annual)
Level (-2.6338)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.0634)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Stock Forecast FAQ

In the current month, BCPC has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BCPC average analyst price target in the past 3 months is $191.00.

  • Where Will Balchem Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Balchem Corp. share price will rise to $191.00 per share over the next 12 months.

  • What Do Analysts Say About Balchem Corp.?

    Analysts are divided on their view about Balchem Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Balchem Corp. is a Sell and believe this share price will drop from its current level to $162.00.

  • What Is Balchem Corp.'s Price Target?

    The price target for Balchem Corp. over the next 1-year time period is forecast to be $191.00 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is BCPC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Balchem Corp. is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of BCPC?

    You can purchase shares of Balchem Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Balchem Corp. shares.

  • What Is The Balchem Corp. Share Price Today?

    Balchem Corp. was last trading at $157.14 per share. This represents the most recent stock quote for Balchem Corp.. Yesterday, Balchem Corp. closed at $156.63 per share.

  • How To Buy Balchem Corp. Stock Online?

    In order to purchase Balchem Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock